Iovera is a cryoanalgesia technology that allows healthcare providers to block pain for immediate and long-term relief by delivering precise cold therapy to a targeted nerve.
It has shown long-term effectiveness in the treatment of knee pain, stopping nerves from sending pain signals for up to 90 days.
It is administered with a nonsurgical handheld device and does not cause any damage to the surrounding knee tissue.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
